Medtronic hires Gregory Zimprich as financial comms director

Medtronic hires Gregory Zimprich as financial comms director

Zimprich joins from Honeywell, where he led global business communications.

Five things for pharma marketers to know: Tuesday, February 13, 2018

Five things for pharma marketers to know: Tuesday, February 13, 2018

Amazon moves into medical supply market; Big Pharma gets a tax cut; Former Celgene CEO plans Senate run.

Infographic | Highlighting top healthcare trends

Infographic | Highlighting top healthcare trends

There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy to lose sight of everything else. PwC's Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.

Purdue Pharma stops marketing opioids to doctors

Purdue Pharma stops marketing opioids to doctors

The pharma company manufactures the well-known opioid OxyContin.

Study: Only one-quarter of clinicians comfortable with value-based payment program

Study: Only one-quarter of clinicians comfortable with value-based payment program

Healthcare providers may understand its importance, but across the board not many are ready to meet the requirements of the program QPP, according to a study.

Payers: High-deductible health plans don't drive positive consumer behavior

Payers: High-deductible health plans don't drive positive consumer behavior

As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.

Five things for pharma marketers to know: Monday, February 12, 2018

Five things for pharma marketers to know: Monday, February 12, 2018

White House limits guidance documents; Top executives exit Axovant; Carroll nominated as drug czar.

10 myths about millennials and their healthcare habits

10 myths about millennials and their healthcare habits

More has been written about millennials — and their healthcare habits — than about any other generation. Here, Gen Y marketers explain why most of what you've read is wrong.

Five things for pharma marketers to know: Friday, February 9, 2018

Five things for pharma marketers to know: Friday, February 9, 2018

Study: Two prostate cancer drugs delay metastasis by two years; Budget deal funds CHIP for four years; Azar outlines Trump's drug pricing plans.

PhRMA takes Let's Talk About Cost campaign to the public

PhRMA takes Let's Talk About Cost campaign to the public

PhRMA wants to clear the air about drug pricing with the consumer-focused extension of the Let's Talk About Cost campaign.

Latest set of Humira commercials debuts to mixed patient response

Latest set of Humira commercials debuts to mixed patient response

Critics said the initial spots unnecessarily blamed IBD sufferers.

Five things for pharma marketers to know: Thursday, February 8, 2018

Five things for pharma marketers to know: Thursday, February 8, 2018

FDA approval of Gilead HIV drug prompts ViiV patent suit; Poll shows split in voter reaction to Trump opioid plan; Outcome Health partners with CDC.

2018 MAHF: Leverte 'was as good with clients as anyone you've ever seen'

2018 MAHF: Leverte 'was as good with clients as anyone you've ever seen'

Zero people have such tales about Robert Leverte, which is why news of his pending induction into the Medical Advertising Hall of Fame was received warmly when it was made public last October.

Big Predictions: Agency gurus on the future of data in the industry

Big Predictions: Agency gurus on the future of data in the industry

We asked some of the agency world's sharpest data people to answer a pair of questions about the future of data in and around pharma marketing. Here's what they had to say.

Five things for pharma marketers to know: Wednesday, February 7, 2018

Five things for pharma marketers to know: Wednesday, February 7, 2018

Study casts doubt on employee wellness programs; FDA identifies kratom as an opioid; House passes bill to modify ACA restaurant menu rules.

High five: How these companies are leveraging data to engage A-list HCPs

High five: How these companies are leveraging data to engage A-list HCPs

In the past, pharma hasn't used data effectively to engage its A-list HCPs. Five companies hope to change that.

Capgemini expands digital chops with LiquidHub acquisition

Capgemini expands digital chops with LiquidHub acquisition

LiquidHub formed a health- and life-sciences-focused offering last June after acquiring Eveo.

Ashfield Healthcare names Doug Burcin president

Ashfield Healthcare names Doug Burcin president

Burcin, who joins from Klick Health, is the former Global CEO of Havas Health.

New entrants shake up agency M&A market as ad groups are 'distracted' by restructuring

New entrants shake up agency M&A market as ad groups are 'distracted' by restructuring

The agency M&A market is changing as the big ad groups have been "distracted" by internal restructuring and new acquirers are emerging.

Five things for pharma marketers to know: Tuesday, February 6, 2018

Five things for pharma marketers to know: Tuesday, February 6, 2018

Allergan Q4 earnings beat estimates; Mars publishes research policies; Conway takes control of White House opioid agenda.

Omnicom Health acquires Snow Companies

Omnicom Health acquires Snow Companies

Snow Companies, which emphasizes patient storytelling, was founded by Brenda Snow in 2001.

McCann Worldwide broaches #MeToo with internal memo

McCann Worldwide broaches #MeToo with internal memo

McCann Worldwide has sent a memo to staff to encourage them to speak up if they face a 'behaviour or concern' in the workplace.

Five things for pharma marketers to know: Monday, February 5

Five things for pharma marketers to know: Monday, February 5

Opdivo hits key goal in late-stage trial; Philippines government sues Sanofi over anti-dengue vaccine; hospitals reach capacity amid record flu season.

Real-world evidence: It's finally having its moment

Real-world evidence: It's finally having its moment

Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled

Merck hands off to Jim Kelly for Super Bowl, World Cancer Day combo campaign

Merck hands off to Jim Kelly for Super Bowl, World Cancer Day combo campaign

This year, the Super Bowl and World Cancer Day fall on the same date.

Five things for pharma marketers to know: Friday, February 2

Five things for pharma marketers to know: Friday, February 2

AstraZeneca strikes deals with Alibaba, Tencent; NY AG sues opioid maker; Justice Department wants more info on CVS-Aetna deal.

Cost over sight? Spark's blindness cure has the industry talking

Cost over sight? Spark's blindness cure has the industry talking

Spark has priced its cure for a rare form of blindness at $425,000 per eye. But rather than the science or the cost, pharma is buzzing over the company's outcomes-based pricing model

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.

Publicis Health names Alexandra von Plato as CEO

Publicis Health names Alexandra von Plato as CEO

The network also appointed her predecessor, Nick Colucci, as COO of Publicis Communications North America, effective immediately.

ABC News' Dan Childs joins Bayer in external comms role

ABC News' Dan Childs joins Bayer in external comms role

Childs has worked at the network news division for more than a decade.

Five things for pharma marketers to know: Thursday, February 1

Five things for pharma marketers to know: Thursday, February 1

Vertex moves two cystic fibrosis drugs into Phase III trials; American Heart Association says breast cancer survivors have higher risk of cardiovascular disease; Blood test to predict Alzheimer's shows promise.

W2O hires Edelman's Rita Glaze to lead value, pricing, market access practice

W2O hires Edelman's Rita Glaze to lead value, pricing, market access practice

Glaze worked in Edelman's market access practice for more than seven years.

As CAR-Ts go from candidates to brands, what's the marketing strategy?

As CAR-Ts go from candidates to brands, what's the marketing strategy?

Strategies for differentiating CAR-T therapies emerge in the early days of 2018, while competitors race to catch up with Novartis and Gilead.

Easterseals Southern California campaign aims to change perceptions of disabilities

Easterseals Southern California campaign aims to change perceptions of disabilities

The nonprofit worked with creative agency E/LA on the push.

Get to know your data scientist: Four data aces share their knowledge

Get to know your data scientist: Four data aces share their knowledge

Four data aces share their backgrounds, inspirations, and guiding philosophies

Five things for pharma marketers to know: Wednesday, January 31, 2018

Five things for pharma marketers to know: Wednesday, January 31, 2018

CDC chief resigns; Amazon healthcare entry raises data concerns; Trump promises to make lower drug prices 'a priority'

Burson-Marsteller UK poaches MSLGroup's Avril Lee to lead healthcare

Burson-Marsteller UK poaches MSLGroup's Avril Lee to lead healthcare

Burson-Marsteller has appointed MSLGroup's EMEA head of healthcare to lead its own health practice in the UK, PRWeek has learned.

Prime Therapeutics signs outcomes-based contract for Jardiance

Prime Therapeutics signs outcomes-based contract for Jardiance

Jardiance treats patients with type 2 diabetes and heart disease, lowering blood sugar and reducing the risk of death from heart disease.

Five things for pharma marketers to know: Tuesday, January 30, 2018

Five things for pharma marketers to know: Tuesday, January 30, 2018

Amazon, Berkshire Hathaway, and JPMorgan team up to form a healthcare company; Takeda's Zika vaccine receives FDA fast-track status

Publicis picks Microsoft to build AI platform Marcel

Publicis picks Microsoft to build AI platform Marcel

Publicis Groupe has announced it has selected Microsoft has the technology partner to deliver its artificial intelligence platform Marcel.

Pfizer UK public affairs lead joins Edelman

Pfizer UK public affairs lead joins Edelman

Alan Maine has joined Edelman as a senior director in its London health team.

Five things for pharma marketers to know: Monday, January 29, 2018

Five things for pharma marketers to know: Monday, January 29, 2018

Outcome Health settles fraud allegations, reassigns leaders; Approval of generics surges during first year of Trump administration; Sanofi acquires coveted biotech firm.

Farm Journal Media partners with WPP firms on Trust in Food campaign

Farm Journal Media partners with WPP firms on Trust in Food campaign

WPP was brought on to help with consumer education about the food industry.

Why pharma ads are on the bench during this year's Super Bowl

Why pharma ads are on the bench during this year's Super Bowl

For some pharma brands, the price tag is just too high. For others, the platform isn't serious enough.

Read the January 2018 Digital Edition

Read the January 2018 Digital Edition

Read the January 2018 issue in its entirety.

Five things for pharma marketers to know: Friday, January 26, 2018

Pharma groups upped lobbying spend in 2017; Novartis, Bayer heads dine with Trump at Davos; Illumina wins jury verdict against Roche subsidiary

Fidelino, Levy named Cannes Lions Health jury presidents

Fidelino, Levy named Cannes Lions Health jury presidents

Fidelino served on the Health & Wellness jury in 2015 and the Pharma jury last year. Levy has been a member of both Health category juries and was a speaker at the first Health Lions in 2014.

Somatix picks Finn Partners as marcomms AOR

Somatix picks Finn Partners as marcomms AOR

Somatix is a digital health platform that tracks movements through smartwatches.

Five things for pharma marketers to know: Thursday, January 25, 2018

Five things for pharma marketers to know: Thursday, January 25, 2018

Senate confirms Azar as HHS head; Spark licenses Luxturna to Novartis outside the U.S.; Glaxo and J&J top index of superbug combatants

Global adspend growth to accelerate to 4.7% in 'stellar' 2018

Global adspend growth to accelerate to 4.7% in 'stellar' 2018

Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).

WPP cuts ties with men-only event where women were 'harassed' and 'groped'

WPP cuts ties with men-only event where women were 'harassed' and 'groped'

WPP has become embroiled in a row over sexism and misogyny following an exposé into the lewd behaviour of a men-only event sponsored by the advertising giant in London.

Five things for pharma marketers to know: Wednesday, January 24, 2018

Five things for pharma marketers to know: Wednesday, January 24, 2018

Novartis sees single-digit growth with new CEO; J&J takes $13.6b charge in the wake of the new tax law; New York City invests in biotech

Flexion's pivot proves pain-free

Flexion's pivot proves pain-free

Clayman says the company's next 18 months are all about Zilretta, with further pipeline construction next up.

Five things for pharma marketers to know: Tuesday, January 23, 2018

Five things for pharma marketers to know: Tuesday, January 23, 2018

FDA issues new policies for compounded drugs; U.S. doctors test CRISPR on cancer patients for the first time; Palio merged into GSW

Back to the Future: Print media thrives in point of care

Back to the Future: Print media thrives in point of care

Not only isn't print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it's thriving in a most unlikely environment: the point of care

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

Some microinfluencers see the latest YouTube guidelines as a "slap in the face."

Nick Law quits R/GA for lead creative role across Publicis Groupe

Nick Law quits R/GA for lead creative role across Publicis Groupe

Nick Law, the global chief creative officer of R/GA, is leaving the company after 17 years to take on the newly created role of chief creative officer across Publicis Groupe and president of Publicis Communications.

Five things for pharma marketers to know: Monday, January 22, 2018

Five things for pharma marketers to know: Monday, January 22, 2018

Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia

Jennifer Gottlieb named W2O Group president

Jennifer Gottlieb named W2O Group president

She is overseeing three of the network's agencies in the newly created role.

Google: slow mobile pages will hurt your ranking

Google: slow mobile pages will hurt your ranking

Advertisers have until July to get their mobile pages up to speed.

Five things for pharma marketers to know: Friday, January 19, 2018

Five things for pharma marketers to know: Friday, January 19, 2018

Biogen, UCB reportedly showing interest in Acorda acquisition; Kite Pharma and Pfizer to develop combo lymphoma therapy; hospitals to form generics nonprofit

Five things for pharma marketers to know: Thursday, January 18, 2018

Five things for pharma marketers to know: Thursday, January 18, 2018

Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution

Why Greater Than One's Elizabeth Apelles stands firm on independence

Why Greater Than One's Elizabeth Apelles stands firm on independence

The CEO of the independent healthcare agency discusses growing a business in digital in the early 2000s and the perks of remaining independent.

YouTube announces measures to earn back trust from advertisers and agencies

YouTube announces measures to earn back trust from advertisers and agencies

In an effort to assure advertisers and agencies on brand safety, Google has announced two new requirements for video creators that intend to join the YouTube Partner Program.

Five things for pharma marketers to know: Wednesday, January 17, 2018

Five things for pharma marketers to know: Wednesday, January 17, 2018

Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer

Sandoz lines up potential third-to-market Humira copy

Sandoz lines up potential third-to-market Humira copy

Although if approved, it's not likely to launch in the U.S. for quite some time.

New tactics change clinical trial awareness game

New tactics change clinical trial awareness game

Recruitment for clinical trials has never been easy. New tools and tactics could change that — assuming the sheer volume of information doesn't overwhelm trial organizers.

McCann Health promotes Marcus Sigurdsson to global chief digital officer

McCann Health promotes Marcus Sigurdsson to global chief digital officer

Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.

Five things for pharma marketers to know: Tuesday, January 16, 2018

Five things for pharma marketers to know: Tuesday, January 16, 2018

Merck's Keytruda combo therapy succeeds in Phase-III lung cancer trial; FDA launches pilot to address trial transparency; Spark's Luxturna overpriced, ICER says

Can digital tools really change patient behavior?

Can digital tools really change patient behavior?

New research calls into question the behavioral effects of some digital health tools.

What Facebook's news feed changes mean for brands and publishers

What Facebook's news feed changes mean for brands and publishers

Facebook's decision to reprioritise its news feed to favour "social interactions" over other forms of content may please its users but will be challenging for brands.

Five things for pharma marketers to know: Friday, January 12, 2018

Five things for pharma marketers to know: Friday, January 12, 2018

Pharma looks to Spark for pricing blueprint; Ipsen hires Amgen exec as CEO of North America; FDA could improve social-media approach, study finds

Stagwell's Penn says digital marketing agencies are 'undervalued' as he eyes more M&A

Stagwell's Penn says digital marketing agencies are 'undervalued' as he eyes more M&A

The founder of Stagwell has claimed digital marketing agencies are undervalued because investors still fail to appreciate how much digital communications and e-commerce are going to transform the economy.

NORML balances federal, local action after Cole memo reversal

NORML balances federal, local action after Cole memo reversal

Once Attorney General Jeff Sessions reversed the Cole memo, NORML began applying pressure both locally and nationally for changes in marijuana laws.

Day 3 at JP Morgan '18: More data, more questions

Day 3 at JP Morgan '18: More data, more questions

Collecting and analyzing data is a contentious question. High-profile data mavens offered some possible answers yesterday at the JP Morgan Healthcare Conference.

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Infographic | Docs, payers need pharma to step up

Infographic | Docs, payers need pharma to step up

For all the talk about new and better ways to engage, pharma still hasn't created an appreciably higher volume of satisfied — or informed — customers.

Day 2 at JP Morgan '18: Pharma's need for more diversity and data sharing grab the spotlight

Day 2 at JP Morgan '18: Pharma's need for more diversity and data sharing grab the spotlight

A plea for IT interoperability and a stinging criticism of the pharma industry over its lack of diversity were two highlights of yesterday's events.

Five things for pharma marketers to know: Wednesday, January 10, 2018

Five things for pharma marketers to know: Wednesday, January 10, 2018

Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict

No Google, no problem: Pharma partners with China's tech giants

No Google, no problem: Pharma partners with China's tech giants

In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market

Day 1 at JP Morgan '18: Easier access to cash spells more M&A, say pharma CEOs

Day 1 at JP Morgan '18: Easier access to cash spells more M&A, say pharma CEOs

How drugmakers should prepare for and respond to the forces poised to reshape the industry was a popular topic on day one of the 36th annual JP Morgan Healthcare Conference.

Five things for pharma marketers to know: Tuesday, January 9, 2018

Five things for pharma marketers to know: Tuesday, January 9, 2018

Shire considers splitting into two units; New Jersey finalizes physician-pharma gift limit; more biotech M&As expected in 2018

MM&M launches 2018 search for Healthcare Transformers and Innovation Catalysts

MM&M launches 2018 search for Healthcare Transformers and Innovation Catalysts

MM&M is calling for nominations for the 2018 class of Top 40 Healthcare Transformers and is seeking industry input for the Top 10 Innovation Catalysts.

Accenture: Large-scale agency M&A is 'not our game' as we have 'amazing momentum'

Accenture: Large-scale agency M&A is 'not our game' as we have 'amazing momentum'

Accenture will not consider a takeover bid for a large ad agency group because its chief executive says there has been a "100%" failure rate with such deals.

WPP names Karen Blackett as its first UK country manager

WPP names Karen Blackett as its first UK country manager

WPP has named Karen Blackett as its first UK country manager, making her the most important agency leader in the British ad industry.

Five things for pharma marketers to know: Monday, January 8, 2018

Five things for pharma marketers to know: Monday, January 8, 2018

Celgene to buy Impact Biomedicines for up to $7 billion; Pfizer plans to cut 300 positions in neuroscience; Perrigo hires new CEO

How healthbots can assist patients and HCPs

How healthbots can assist patients and HCPs

As HCPs continue to be stretched for time to diagnose and interact with patients, health bots could help reduce HCP workload and drive patient engagement.

The buyer's guide to pharma, healthcare, and life sciences consultancies

The buyer's guide to pharma, healthcare, and life sciences consultancies

Do the healthcare and pharma arms of Accenture, Deloitte, PwC, and other consultancies pose an existential threat to traditional healthcare agencies?

Five things for pharma marketers to know: Friday, January 5, 2018

Five things for pharma marketers to know: Friday, January 5, 2018

Takeda announces deals worth more than $1 billion; biotech and pharma investments reached $10.5 billion in 2017; prescriptions for nerve pain on the rise

From working for one administration to fending off another: Planned Parenthood's Kevin Griffis

From working for one administration to fending off another: Planned Parenthood's Kevin Griffis

Kevin Griffis brought his experience in government and politics to Planned Parenthood at the perfect time, leading the fight to protect birth control coverage under the Trump administration and destigmatizing abortion.

Bank brand creates own algorithm to avoid YouTube ad pitfalls

Bank brand creates own algorithm to avoid YouTube ad pitfalls

US bank JPMorgan Chase has returned to advertising on YouTube only after developing its own algorithm that ensures its ads are not placed around questionable content.

Five things for pharma marketers to know: Thursday, January 4, 2018

Five things for pharma marketers to know: Thursday, January 4, 2018

Allergan to cut 1,000 jobs; McKesson acquires RxCrossroads from CVS Health; Pfizer and Sangamo enter collaboration to develop ALS gene therapy

Five things for pharma marketers to know: Wednesday, January 3, 2018

Five things for pharma marketers to know: Wednesday, January 3, 2018

Utah Senator who backed Orphan Drug Act will not seek reelection; medicines more expensive in 2018; Spark's genetic therapy for rare blindness costs $850,000

Should pharma fear ICER?

Should pharma fear ICER?

The group's reports, received with great interest by insurers and the Department of Veteran Affairs, have concluded certain high-profile drugs aren't worth the cost. Pharma still hasn't decided whether ICER is friend or foe.

CPG companies Nestlé and Kellogg court OTC

CPG companies Nestlé and Kellogg court OTC

A sea change may be afoot in OTC, with multiple healthcare businesses in play. Could consumer goods companies fill the void left by big pharma?

Five things for pharma marketers to know: Tuesday, January 2, 2018

Five things for pharma marketers to know: Tuesday, January 2, 2018

FDA approvals hit a 21-year high; drug prices account for higher U.S. healthcare spend; industry enters 2018 amidst consolidation, uncertainty

Five things for pharma marketers to know: Thursday, December 28, 2017

Five things for pharma marketers to know: Thursday, December 28, 2017

Study: male docs earn more than female peers; new Michigan law tackles opioid crisis; study: some docs billed Medicare for most expensive patient visit type

MM&M's 5 most-read technology stories of 2017

MM&M's 5 most-read technology stories of 2017

Digital innovation in Japan, health-tech trends, and social media top the list.

VA reaches out to agencies about recruitment campaign

VA reaches out to agencies about recruitment campaign

The Department of Veteran Affairs issued an RFI at the end of November for a nationwide healthcare professional recruitment campaign.

Five things for pharma marketers to know: Wednesday, December 27, 2017

Five things for pharma marketers to know: Wednesday, December 27, 2017

Mallinckrodt to buy Sucampo for $1.2 billion; Amazon pushes digital advertising in 2018; WHO classifies gaming disorder as mental health condition